The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
Background. Neuropathic pain is a complex sort of pain that is detrimental to individuals’ health, both physically and mentally, but merely a small portion of them could witness pain alleviation. Mirogabalin, by distinctive binding characteristics of voltage-gated calcium channels, has won approval...
Main Authors: | Hui Tang, Jing Lu, Yazhuo Duan, Dejun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2023/4893436 |
Similar Items
-
Mirogabalin, a selective gabapentinoid for managing neuropathic pain—A curtain raiser
by: Abhijit Nair
Published: (2022-01-01) -
Safety, tolerability, and efficacy of a selective gabapentinoid mirogabalin in neuropathic pain—a topical review
by: Abhijit Nair, et al.
Published: (2021-10-01) -
Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions
by: Weronika Gawel, et al.
Published: (2023-01-01) -
Determinants of interactions of a novel next-generation gabapentinoid NVA1309 and mirogabalin with the Cavα2δ-1 subunit
by: Ivana A. Souza, et al.
Published: (2024-08-01) -
Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study
by: Tomoko Tetsunaga, et al.
Published: (2020-05-01)